Ruxolitinib
Medication
Ratings
0
Nobody has rated this yet. Be the first!
The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation
Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib